All participants will be asked to fill in an evaluation form after the conference. Your answers will help us improve the event next year.
Participants will have until January 8th to fill-out the evaluation form in order to obtain their CME certificates; which will be granted based on the total time spent on the SOA activities from December 14 until January 8th.
After January 8th, the time spent per user will be calculated and the certificates will be sent on Friday January 15th (at the latest).
Certificates will be sent only to the participants who completed the evaluation form.
ESGO 2020 Virtual Conference: A decade of advances in gynaecological cancer care
When it comes to meeting the right people in the right place, the 4th ESGO State of the Art Conference of the European Society of Gynaecological Oncology is a special event you don't want to miss in 2020...
ESGO 2020 brings together attendees from around the world for a unique 3-days gathering where the attendees can experience highly interactive format of the sessions and discuss the latest developements with key experts in the field of gynaecological oncology.
ESGO has been following all current regulations, recommendations and updates connected to Covid-19 pandemic and after a careful consideration we can have decided to change our conference to a purely virtual meeting.
ESGO 2020 Highlights
+ Exclusive focus on the evidence base guidelines and standard operational procedures to manage gynecological cancers.
+ Comprehensive state-of-the art summaries on the advances in the management of Cervical, Endometrial, Ovarian and Vulvar cancers.
+ Up-to-date scientific reviews on the clinical trial landscape in collaboration with the European Network of Gynaecological Oncological Trial Groups (ENGOT)
+ New Format: Interactive Debates with key opinion leaders
+ Hybrid format for participants that cannot attend due to travel restriction in their country
The sessions will open with a case presentation followed by a keynote lecture and a debate with a panel of world experts to discuss the therapeutic approaches and recent advances.